Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agents

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-62172-4
Affiliations:
9
Authors:
14
Go to article
Institutions Authors Share
University of Alberta (U of A), Canada
11.000000
11.000000
 0.79
Duke University, United States of America (USA)
2.000000
 0.14
University of Ottawa Heart Institute, Canada
1.000000
 0.07
Interested in Cardiovascular Medicine and Haematology?